Insights into recent findings and clinical application of YAP and TAZ in cancer

JM Franklin, Z Wu, KL Guan - Nature Reviews Cancer, 2023 - nature.com
Decades of research have mapped out the basic mechanics of the Hippo pathway. The
paralogues Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding …

EGFR in cancer: Signaling mechanisms, drugs, and acquired resistance

ML Uribe, I Marrocco, Y Yarden - Cancers, 2021 - mdpi.com
Simple Summary Growth factors are hormone-like molecules able to promote division and
migration of normal cells, but cancer captured the underlying mechanisms to unleash tumor …

[HTML][HTML] The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases

MR Zinatizadeh, B Schock, GM Chalbatani, PK Zarandi… - Genes & diseases, 2021 - Elsevier
The nuclear factor kappa B (NF-êB) family of transcription factors plays an essential role as
stressors in the cellular environment, and controls the expression of important regulatory …

Hippo signaling pathway and respiratory diseases

W Tang, M Li, X Yangzhong, X Zhang, A Zu… - Cell Death …, 2022 - nature.com
The hippo signaling pathway is a highly conserved evolutionary signaling pathway that
plays an important role in regulating cell proliferation, organ size, tissue development, and …

The hippo pathway effectors YAP/TAZ-TEAD oncoproteins as emerging therapeutic targets in the tumor microenvironment

RB Mokhtari, N Ashayeri, L Baghaie, M Sambi, K Satari… - Cancers, 2023 - mdpi.com
Simple Summary YAP/TAZ are the central effectors of the Hippo pathway and orchestrate
their oncogenic program by binding to TEAD transcriptional factors. Here, we document a …

Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer

Y Li, T Mao, J Wang, H Zheng, Z Hu, P Cao… - Cell Communication and …, 2023 - Springer
Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is currently the
standard first-line therapy for EGFR-mutated advanced non-small cell lung cancer (NSCLC) …

The importance of being PI3K in the RAS signaling network

C Cuesta, C Arévalo-Alameda, E Castellano - Genes, 2021 - mdpi.com
Ras proteins are essential mediators of a multitude of cellular processes, and its
deregulation is frequently associated with cancer appearance, progression, and metastasis …

Targeted intervention of NF2–YAP signaling axis in CD24-overexpressing cells contributes to encouraging therapeutic effects in TNBC

L Hou, L Pu, Y Chen, Y Bai, Y Zhou, M Chen, S Wang… - ACS …, 2022 - ACS Publications
Triple-negative breast cancer (TNBC) cells have not been usefully classified, and no
targeted therapeutic plans are currently available, resulting in a high recurrence rate and …

Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck …

YL Lo, HC Lin, WH Tseng - Acta Biomaterialia, 2022 - Elsevier
Prospective tumor pH-responsive and charge-convertible nanoparticles have been utilized
to reduce side effects and improve the active tumor-targeting ability and nuclear/cytoplasmic …

[HTML][HTML] Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis

NTN Trang, CY Lai, HC Tsai, YL Huang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Osteosarcoma is a highly mortal bone tumor, with a high metastatic potential, promoted in
part by the enzyme procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2). Increasing …